跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BRIVLERA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
BRIVLERA
Authorized
STANDARD
BRIVLERA
UCB Canada Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
d6ce990f7143ee50
Company
UCB Canada Inc
Type
Standard
Approval Details
Approval Id
d6ce990f7143ee50
Drug Approval Canada Name
BRIVLERA
Product Name
BRIVLERA
Status
Marketed
Status Date
2020-04-06
Original Market Date
2020-04-06
Din
02452987
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:12.92
Atc Original
N03AX23 BRIVARACETAM
Atc Name
n 03 ax 23
Aig Number
0157931001
Company Name
UCB Canada Inc
Company Address
602, 2201 Bristol Circle, Oakville, Ontario, Canada, L6H 0J8
Active Ingredients
BRIVARACETAM
10 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
d6ce990f7143ee50
Type
Standard
Back to Health Canada Approvals